Page last updated: 2024-10-31

milrinone and Experimental Lung Inflammation

milrinone has been researched along with Experimental Lung Inflammation in 1 studies

Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.

Research Excerpts

ExcerptRelevanceReference
"Two authors searched MEDLINE, PubMed, Embase, Science Direct, Cochrane Central Register of Controlled Trials, the Cochrane Library, Wanfang database, Chinese Biomedical Literature Database, China National Knowledge Infrastructure (CNKI) for randomized controlled trials (RCTs) about the application of milrinone in the treatment of heart failure caused by severe pneumonia in children with CHD in children up to December 10, 2022."9.41Milrinone for the treatment of heart failure caused by severe Pneumonia in children with congenital heart disease: a meta-analysis. ( Cai, L; Diao, S; Shao, W; Zhou, L, 2023)
"Two authors searched MEDLINE, PubMed, Embase, Science Direct, Cochrane Central Register of Controlled Trials, the Cochrane Library, Wanfang database, Chinese Biomedical Literature Database, China National Knowledge Infrastructure (CNKI) for randomized controlled trials (RCTs) about the application of milrinone in the treatment of heart failure caused by severe pneumonia in children with CHD in children up to December 10, 2022."5.41Milrinone for the treatment of heart failure caused by severe Pneumonia in children with congenital heart disease: a meta-analysis. ( Cai, L; Diao, S; Shao, W; Zhou, L, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shao, W1
Diao, S1
Zhou, L1
Cai, L1

Reviews

1 review available for milrinone and Experimental Lung Inflammation

ArticleYear
Milrinone for the treatment of heart failure caused by severe Pneumonia in children with congenital heart disease: a meta-analysis.
    BMC pediatrics, 2023, 10-28, Volume: 23, Issue:1

    Topics: Child; China; Heart Defects, Congenital; Heart Failure; Humans; Milrinone; Pneumonia

2023